SOURCE-TRACEABLE ARCHIVE

Amoxil阿莫西林

This page links to public primary-source material for Amoxil. The archive is historical or documentary evidence only; it does not by itself establish originator status, product quality, current labelling, availability or sale eligibility.

LABEL USE SNAPSHOT

What the cited U.S. label covers

U.S. FDA label snapshot, revised May 2024: for certain infections due to susceptible organisms in the ear, nose and throat, genitourinary tract, skin and skin structures, and lower respiratory tract; specified adult H. pylori and duodenal-ulcer combination treatment is also listed.

It is source-reading context, not an individual diagnosis, prescription, substitution or purchasing recommendation. Check the current label in the target market.

How to read this record

Read each document in its stated market, date and dosage-form context. A historical record is not a current label and does not support individual medical, substitution or purchasing conclusions.

Keep international and mainland China records separate

This page has a U.S. public history/regulatory archive but no mainland China record for this specific product. That does not establish whether the medicine exists, is approved or is available in mainland China. Verify product identity, dosage form, strength, holder and the current label item by item.

CDE listed-drug directory ↗ NMPA public query ↗

Evidence status

The listed links are public sources selected for traceability. They must be rechecked against the current target-market record before any use beyond reading and research.